Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826290 · ClinicalTrials.gov registry record · NA
Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record
A NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 13,155
- Enrollment target
- 1
- Study location
NCT03826290: Completed NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, sponsored by University of Utah.
NCT03826290 is a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus that has completed, run by University of Utah. The registered enrollment target is 13,155 participants, above the 4,448-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (196% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03826290, a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 13,155 participants
- Enrollment target
- 1
- Study location
Study Summary
Diabetes is a significant medical problem in the United States and across the world. Despite significant progress in understanding how to better manage diabetes, there is oftentimes still uncertainty in the optimal management strategy for a specific patient. As a result, providers and patients must often use a trial-and-error approach to identify an effective treatment regimen. The objective of this research is to evaluate a diabetes dashboard integrated with the electronic health record (EHR) that has been developed as a collaborative project between the University of Utah and Hitachi, Ltd. This dashboard tool provides a graphical overview of the patient's relevant data parameters as well as information on the impact of different treatment options on previous patients with similar characteristics. The different treatment options compare the predicted impact of relevant medication regimens as well as weight loss. Primary care clinics are randomized to either an intervention condition where the tool is available or to a control condition where the tool is not yet available. Patients' hemoglobin A1c levels (a measure of diabetes control) are the main outcome variable. Other secondary analyses will also be conducted. Use of the tool will be encouraged but optional. Following any suggestions made in the tool will also be optional and up to the discretion of the clinician.
Primary Outcome
Each patient's HbA1c level will be estimated for the beginning and end of the evaluation period. For each of these time points, the value at that time point will be estimated as follows. If a value exists for that date, use that. Otherwise, for the beginning date, first take the earliest value within the evaluation period (anchor value). If there are no values before the evaluation period, then use the anchor value. Otherwise, take the latest value before the evaluation period, and interpolate w
Conditions Studied
Interventions
- OTHER EHR-integrated diabetes dashboard
Study Locations (1)
Utah
- University of Utah Health - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,155 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-07-01 |
| Phase | NA |
What the finished NCT03826290 record still lists
NCT03826290 is an interventional study that assigns participants to a tested intervention. Its 13,155 participants enrollment target places it among the larger protocols in the corpus, above the 4,448-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (196% higher).
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which EHR-integrated diabetes dashboard is the first listed.
NCT03826290 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT03826290 about?
NCT03826290 is a clinical study titled "Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record". Diabetes is a significant medical problem in the United States and across the world. Despite significant progress in understanding how to better manage diabetes, there is oftentimes still uncertainty in the optimal management strategy for a specific patient. As a result, providers and patients must ...
What is the current status of trial NCT03826290?
This trial is currently completed. It is a NA study. The enrollment target is 13,155 participants. The study started on 2019-01-01. Estimated completion is 2020-07-01.
What conditions does trial NCT03826290 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus.
What interventions are being tested in trial NCT03826290?
The interventions under investigation include: EHR-integrated diabetes dashboard (OTHER).
Who is sponsoring clinical trial NCT03826290?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03826290 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03826290's enrollment target sits among peer trials
13,155 9th of 348 higher than 340 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- NCT07028398 · 12,990 participants · NA
CMSL Ambulatory Sensitive Condition Nudge Study 2
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI